Chinook Therapeutics, Inc. (KDNY)

Last Three Months

02-Nov-22 -- 01-Feb-23

Time Period:

Three Months
|
Year

0 Net Amount

Buy:	0	--
Sell:	0	--

Company Sentiment

Biotechnology

Drugs

Insider Trading Sentiment: Reduce

Insider Trading Sentiment: Buy

Sentiment Breakdown by Insider

0

(3)

0

(2)

2

(1)

22

0

2

+1

0

+2

0

+3

Two Year Chart

02-Feb-21 -- 01-Feb-23

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
15-Dec-22 4:27 PM View:	14-Dec-22 Option Exercise $10.50K	Dobmeier Eric President, CEO Director		Chinook Therapeutics, Inc. - KDNY	15% 236.68K to 271.68K	0	0	--	--	Show Txns Hide Txns

02-Dec-22 4:25 PM View:	01-Dec-22 Option Sale ($128.60K)	Bjerkholt Eric Chief Financial Officer		Chinook Therapeutics, Inc. - KDNY	48% 22.2K to 32.85K	0	0	--	--	Show Txns Hide Txns

15-Dec-22 4:28 PM View:	13-Dec-22 Planned Option Sale ($250.00K)	Frohlich Tom Chief Operating Officer		Chinook Therapeutics, Inc. - KDNY	0% 143.91K	0	0	--	--	Show Txns Hide Txns

04-Jan-23 7:44 PM View:	03-Jan-23 Sale (Planned) ($64.55K)	King Andrew James Chief Scientific Officer		Chinook Therapeutics, Inc. - KDNY	(20%) 12.49K to 9.99K	0	0	--	--	Show Txns Hide Txns

27-Dec-22 5:42 PM View:	22-Dec-22 Disposition (other) 0	Jerel Davis Director		Chinook Therapeutics, Inc. - KDNY	(10%) 4.65M to 4.17M	0	0	--	--	Show Txns Hide Txns